Publicaciones en colaboración con investigadores/as de Institut Pasteur (39)

2024

  1. COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022

    Eurosurveillance, Vol. 29, Núm. 13

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  3. Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 26, Núm. 29

2019

  1. #EUROmicroMOOC: using Twitter to share trends in Microbiology worldwide

    FEMS microbiology letters, Vol. 366, Núm. 11

2018

  1. Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies

    Eurosurveillance, Vol. 23, Núm. 9

2017

  1. An objective comparison of cell-tracking algorithms

    Nature Methods, Vol. 14, Núm. 12, pp. 1141-1152

2016

  1. Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics

    Nature Communications, Vol. 7

  2. The Heterogeneity of Ly6Chi Monocytes Controls Their Differentiation into iNOS+ Macrophages or Monocyte-Derived Dendritic Cells

    Immunity, Vol. 45, Núm. 6, pp. 1205-1218

2015

  1. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells

    Science, Vol. 348, Núm. 6238, pp. 1031-1035

2014

  1. Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses

    Journal of Immunology, Vol. 193, Núm. 4, pp. 1787-1798

  2. Conventional but not plasmacytoid dendritic cells foster the systemic virus-induced type I IFN response needed for efficient CD8 T cell priming

    Journal of Immunology, Vol. 193, Núm. 3, pp. 1151-1161

  3. Intravenous immunoglobulin promotes antitumor responses by modulating macrophage polarization

    Journal of Immunology, Vol. 193, Núm. 10, pp. 5181-5189

  4. Objective comparison of particle tracking methods

    Nature Methods, Vol. 11, Núm. 3, pp. 281-289

  5. Simultaneous analysis of large-scale RNAi screens for pathogen entry

    BMC Genomics, Vol. 15, Núm. 1

2012

  1. Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses

    Vaccine, Vol. 30, Núm. 18, pp. 2848-2858

  2. Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin

    International Journal of Cancer, Vol. 131, Núm. 3, pp. 641-651

2010

  1. Single-cell techniques using chromosomally tagged fluorescent bacteria to study Listeria monocytogenes infection processes

    Applied and Environmental Microbiology, Vol. 76, Núm. 11, pp. 3625-3636